We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.08B
AUM Growth
-$109M
Cap. Flow
-$88M
Cap. Flow %
-4.22%
Top 10 Hldgs %
17.5%
Holding
3,019
New
52
Increased
262
Reduced
623
Closed
69

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$2.94M
2
VZ icon
Verizon
VZ
+$2.82M
3
EHC icon
Encompass Health
EHC
+$2.04M
4
WBS icon
Webster Financial
WBS
+$1.98M
5
ABBV icon
AbbVie
ABBV
+$1.93M

Top Sells

Rank Stock Value
1
AMLP icon
Alerian MLP ETF
AMLP
+$16.3M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.26M
3
IJK icon
iShares S&P Mid-Cap 400 Growth ETF
IJK
+$3.76M
4
SIVB
SVB Financial Group
SIVB
+$3.69M
5
AAPL icon
Apple
AAPL
+$3.61M

Sector Composition

Rank Sector Weight
1 Technology 13.98%
2 Financials 13.14%
3 Industrials 10.38%
4 Healthcare 8.96%
5 Consumer Discretionary 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRHC
2176
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$31K ﹤0.01%
799
– –
ADMS
2177
DELISTED
Adamas Pharmaceuticals
ADMS
$31K ﹤0.01%
1,301
– –
CAI
2178
DELISTED
CAI International, Inc.
CAI
$31K ﹤0.01%
1,481
– –
FSB
2179
DELISTED
Franklin Financial Network, Inc.
FSB
$31K ﹤0.01%
950
– –
KERX
2180
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$31K ﹤0.01%
7,631
– –
ABEO icon
2181
Abeona Therapeutics
ABEO
$425M
$30K ﹤0.01%
85
– –
ATEX icon
2182
Anterix
ATEX
$1.74B
$30K ﹤0.01%
1,002
– –
CATO icon
2183
Cato Corp
CATO
$65.7M
$30K ﹤0.01%
2,030
– –
CCBG icon
2184
Capital City Bank Group
CCBG
$896M
$30K ﹤0.01%
1,232
– –
CVNA icon
2185
Carvana
CVNA
$79.7B
$30K ﹤0.01%
6,650
– –
FEMS icon
2186
First Trust Emerging Markets Small Cap AlphaDEX Fund
FEMS
$254M
$30K ﹤0.01%
+675
New +$30.4K
FRO icon
2187
Frontline
FRO
$9.02B
$30K ﹤0.01%
6,759
– –
HSBC icon
2188
HSBC
HSBC
$358B
$30K ﹤0.01%
694
-14
-2% -$666
IPI icon
2189
Intrepid Potash
IPI
$490M
$30K ﹤0.01%
831
– –
LFCR icon
2190
Lifecore Biomedical
LFCR
$181M
$30K ﹤0.01%
2,282
-1,305
-36% -$17.1K
MPAA icon
2191
Motorcar Parts of America
MPAA
$230M
$30K ﹤0.01%
1,400
– –
NMRK icon
2192
Newmark Group
NMRK
$2.68B
$30K ﹤0.01%
+1,962
New +$30.4K
PKE icon
2193
Park Aerospace
PKE
$828M
$30K ﹤0.01%
1,804
– –
PWB icon
2194
Invesco Large Cap Growth ETF
PWB
$2.45B
$30K ﹤0.01%
+710
New +$30.9K
RM icon
2195
Regional Management Corp
RM
$297M
$30K ﹤0.01%
935
– –
VVX icon
2196
V2X
VVX
$2.55B
$30K ﹤0.01%
813
– –
NETI
2197
DELISTED
Eneti Inc.
NETI
$30K ﹤0.01%
457
– –
STML
2198
DELISTED
Stemline Therapeutics, Inc.
STML
$30K ﹤0.01%
1,930
– –
ASNA
2199
DELISTED
Ascena Retail Group, Inc.
ASNA
$30K ﹤0.01%
747
– –
ELGX
2200
DELISTED
Endologix Inc
ELGX
$30K ﹤0.01%
700
-300
-30% -$12.9K
86 87
88
89 90

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

Ameritas Investment Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Ameritas Investment Partners held 3,019 positions worth $2.08B, down 5% from $2.19B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Ameritas Investment Partners withdrew a net $88M in Q1 2018, closing 69 positions and reducing 623 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $1.75M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ameritas Investment Partners opened a new position in Encompass Health worth $2.16M.

  • Ameritas Investment Partners's largest Q1 2018 buy was Encompass Health: 47,494 shares worth $2.16M.
  • Ameritas Investment Partners added most to Visa in Q1 2018, an estimated $2.94M increase.
  • Ameritas Investment Partners's biggest Q1 2018 reduction was Alerian MLP ETF, cutting an estimated $16.3M.
  • Ameritas Investment Partners fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $1.75M.
  • Ameritas Investment Partners's ten largest holdings make up 18% of its $2.08B portfolio in Q1 2018.
  • Ameritas Investment Partners opened 52 new positions and closed 69 in Q1 2018.
  • Ameritas Investment Partners's portfolio value fell 5% quarter-over-quarter to $2.08B.

Based on Ameritas Investment Partners's 13F filing for Q1 2018, filed 15 May 2018.